Fri, 31 Jan 2025
New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC| About | Newsletters | Transcripts
Business News Top © 2024-2025